Valence Life Sciences
North America, New York, United States, New York
Description
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.
Investor Profile
Valence Life Sciences has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 38% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
Stage Focus
- Series Unknown (25%)
- Private Equity (25%)
- Series D (25%)
- Series C (13%)
- Series E (13%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Information Technology
- Life Science
- Manufacturing
- Biopharma
- Health Diagnostics
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
